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Abstract
Techniques currently used for assessment of bacterial count or growth are time-consuming, offer
low throughput, or they are complicated or expensive. The aim of the present work was to elabo-
rate a newmethod that is able to detect the antibacterial effect of cells, subcellular particles, and
soluble compounds in a fast, cost, and labor effective way. Our proposed technique is based on
flow cytometry (FC) optimized for detection of small particles and on fluorescently labeled bac-
teria. It allows direct determination of the bacterial count in 3 hours. The effect of various human
phagocytes and extracellular vesicles on gram-positive and gram-negative bacteria is investigated
in parallel with the new, FC-based method, with colony counting and with our previous, OD-
based method. Comparing the killing effect of wild type and NADPH oxidase-deficient murine
neutrophils presents an example of detection of a clinically important deficiency. Strong corre-
lationwas obtained between the results of the different techniques, but the reproducibility of the
FC-based testwas superior to theOD-based test. Themajor advantages of the new technique are:
rapidity, low cost, high throughput, and simplicity.
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1 INTRODUCTION
The major function of the immune system is to eliminate microorgan-
isms from the host. Estimation of the antibacterial effect of immune
cells or factors is important both in research and in the clinical field.
However, fast and reliable measurement of antibacterial effect is still
a challenging task. Many different methods have been elaborated and
applied hitherto, but as summarized in Table 1, all have serious draw-
backs and a simple, fast, and reliable technique is still lacking. Bacterial
spreading and counting of CFU is regarded by many scientists as the
gold standard, however it requires vast amount of manual labor and
provides results only with a delay of 48 hours.
Flow cytometry (FC) is a powerful technique that is widely used
for determination of various cellular functions and properties both in
research and in clinical diagnostics, but its application in microbiolog-
ical testing is underrepresented. The probable reason is that bacteria
(approx. 0.5–1 𝜇m) are significantly smaller than cells (5–20 𝜇m) and
this size is on the detection limit of most cytometers. Importantly,
fluorescent labeling improves detectability and recent research on
Abbreviations: AO, acridine orange; EV, extracellular vesicles; FC, flow cytometry; LB,
lysogeny broth; NOX, neutrophil oxidase; PMN, polymorphonuclear cell
extracellular vesicles has initiated new approaches extending the
detection limit of FC down to 200 nm.34
In this study, we present a new and simplified FC-based method
to examine the antibacterial effect of any kind of cellular or subcel-
lular samples. We compare our new FC-based method to CFU count-
ing and to the OD-based assay developed and validated earlier in our
laboratory.8 By devising the present test, the main goals were relia-
bility, high throughput, low cost, low waste production, and results in
short time.
2 MATERIALS AND METHODS
2.1 Materials
HBSS with calcium and magnesium but without glucose was from
GE Healthcare Life Sciences (South Logan, UT, USA), Saponin was
from Calbiochem-Novabiochem Corporation (San Diego, CA, USA),
Zymosan A from Sigma Aldrich (St. Louis, MO, USA), Ficoll-Paque and
Percoll from GE Healthcare Bio-Sciences AB (Uppsala, Sweden). The
lysogeny broth (LBmedium) contained 10 g tryptone, 5 g yeast extract,
10gNaCl in1Ldistilledwater, pHwasadjusted to7.0.AcridineOrange
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was from Serva-Feinbiochemica (Heidelberg, Germany). All other used
reagents were of research grade.Methicillin-sensitive S. aureus (ATCC:
29213) and E. coli (ATCC:ML-35) were used. GFP-expressing and chlo-
ramphenicol resistant S. aureus (USA300) was a kind gift of Professor
WilliamNauseef (University of Iowa).
2.2 Preparation of human polymorphonuclear cells
(PMN), monocytes, and erythrocytes
Venous bloodwas drawn fromhealthy human adult volunteers accord-
ing to procedures approved by the National Ethical Committee (ETT-
TUKEB No. BPR/021/01563-2/2015). Red blood cells were separated
from the white blood cells by dextran sedimentation. Thereafter PMN
were separated from the monocyte-lymphocyte fraction by 62.5% v/v
Ficoll gradient centrifugation (700 g, 40 min, 22◦C). Remaining red
blood cell contamination was removed by hypotonic treatment. The
obtained sample contained 95% or more PMN. Monocytes were sep-
arated from the other leukocytes by 46% v/v Percoll gradient centrifu-
gation (700 g, 40 min, 22◦C). The obtained sediment contained mostly
monocytes and some contaminant lymphocytes but no neutrophils. All
cell types were used in 107 cells/mL concentration.
2.3 Mice and isolation ofmurine PMN
Neutrophil oxidase 2 (NOX2)-deficient animals on C57Bl/6J
background35 were a kind gift from Professor Miklós Geiszt
(Semmelweis University, Budapest). All NOX2-deficient mice were
males (NOX2−/0) 11–14 week old. Age- and sex-matched C57Bl/6J
animals were used as controls. Genotyping was performed by allele-
specific PCR.
Murine neutrophils were isolated from the bone marrow of the
femurs and tibias of mice by hypotonic lysis followed by Percoll (GE
Healthcare) gradient centrifugation as previously described.36 Cells
were kept at room temperature in Ca2+- and Mg2+-free medium until
use (usually less than 30 min) and prewarmed to 37◦C before acti-
vation. Neutrophil assays were performed at 37◦C in HBSS supple-
mentedwith 20mMHepes, pH 7.4.
2.4 Opsonization of Zymozan A and bacteria
Zymosan A (5 mg) or 1 mL bacteria (OD600 = 1.0) were opsonized
either with 200 𝜇L pooled human serum or with 800 𝜇L pooledmurine
serum for 20 min at 37◦C. Opsonized particles were centrifuged
(10,000 g, Hermle Z216MK 45◦ fixed angle rotor, 10 min, 4◦C), and
washed, then resuspended in 1mLHBSS.
2.5 Preparation of extracellular vesicles (EV) from
human PMN
PMN were activated with opsonized Zymosan A particles for 20 min
at 37◦C in linear shaking water bath with 80 rpm. After activa-
tion, cells were sedimented (500 g, Hermle Z216MK 45◦ fixed angle
rotor, 5 min, 4◦C). Upper 500 𝜇L of the supernatant was filtered
through a 5 𝜇m pore sterile filter (Sterile Millex Filter Unit, Millipore,
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F IGURE 1 Experimental scheme of CFU counting, theOD and the FC basedmethods
Billerica, MA, USA). The filtered fraction was sedimented (15,700 g,
Hermle Z216MK 45◦ fixed angle rotor, 5 min, 4◦C), the pellet was
carefully resuspended in 500 𝜇L HBSS, followed by addition of 20 𝜇L
LB to each sample. To examine the dose-dependency of EV on bacte-
rial survival, a dilution series of the EV fractions was prepared. Corre-
sponding to our earlier experiments,14 EV derived from 107 PMNwas
taken as reference (1 EV). Compared to this, we prepared diluted (0.1
EV and 0.5 EV) and more concentrated (5 EV) samples. As a negative
control we applied heat-inactivated (20 min, 100◦C, orbital shaking
600 rpm) 1 EV.
2.6 Measurement of bacterial survival
Opsonized bacteria (2.5 × 107) were added to 5 × 106 human cells or
to 500 𝜇L EV suspended in HBSS containing 4% v/v LB or to 5 × 106
murine PMN (in 500 𝜇L HBSS) (Fig. 1). During a 40 min coincubation
step at 37◦C, the bacterial count decreases or increases depending on
the samples’ antibacterial effect and the growth of bacteria. At the end
of the incubation, 2 mL ice-cold stopping solution (1 mg/mL saponin
in HBSS) was added to stop the incubation and lyse cells or EV. After a
freezing step at−80◦C for 20min, samples were thawed to room tem-
perature. Complete release of surviving bacteria from the phagocytes
was controlled both by flow cytometry and fluorescent microscopy
(data not shown). Thus, our test examines true bacterial survival and
not phagocytosis. The initial bacterial count was determined by adding
the same quantity of bacteria to an extra aliquot of HBSS containing
4% v/v LB at the end of the 40 min incubation, immediately before
addition of the ice-cold stopping solution. We termed this sample as
“no growth” sample. Quantification of the samples was performed in
parallel using the CFU counting, the OD and the FC-based method.
Finally, the bacterial survival was expressed in percentage as the ratio
of the bacterial count determined in the 40min and in the “no growth”
samples (Fig. 1).
2.7 CFU countingmethod
Bacterial suspensions were serially diluted and plated on LB-agar in
two parallels to enumerate surviving bacteria. To minimize the impre-
cision due to bacterial contamination, agar plates contained 10 𝜇g/mL
chloramphenicol to ensure selectiveUSA300 up-growth.
2.8 Spectrophotometry-based quantification of
bacterial count
Bacterial growth was followed as changes in OD using a shaking
microplate reader (Labsystems iEMSReaderMF,ThermoScientific) for
8 hours, at 37◦C, at 650 nm (Fig. 1). After the end of this growth phase
the initial bacterial countswere calculated indirectly using an equation
similar to PCR calculation, as described previously.8
2.9 Flow cytometry-based quantification of
bacterial count
Measurements were executed by a BD FACSCalibur flow cytome-
ter, optimized for small particle detection. As both the size and the
refractive index of EV and bacteria are very similar, the gating
procedure was similar to the EV detection and quantitation used
before in.13 Briefly, HBSS was used for setting the thresholds to
eliminate instrument noise (Figs. 2A and B). The upper size limit
of bacterial detection range was set by 3.8 𝜇m fluorescent beads
(SPHERO Rainbow Alignment Particles from Spherotech Inc., USA).
The lower size limit of bacterial detection was set to exclude the
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F IGURE 2 Gating strategy of flow cytometric measurements. In panel A side scatter is presented against forward scatter, whereas in panels B,
C and E–G, green fluorescence is presented against side scatter. (A and B) Representative dot plots on pure HBSS medium to set thresholds. (C)
Representative dot plot on fluorescent beads (3.8 𝜇m) and GFP-expressing S. aureus (diameter ca. 0.8 𝜇m) measured in parallel to set R1 gate; (D)
Calibration of the optimal flow rate range of the BD FACScalibur flow cytometer.USA300 bacteria were used for calibration. The undiluted sample
had an optical density of 1.00 at 600 nm. Bars represent±SEM; n= 5 (E). Representative dot plots onUSA300 bacteria population at start of killing
step, (F) at the end of 40min incubation in HBSS+ 4% LB, and (G) at the end of 40min killing in HBSS+ 4% LBwith human PMN
instrumental noise, thus detected particles were no smaller than
300 nm34 (Fig. 2C). Since the bacteria’s size range (around 500–
1000 nm) is near to the detection limit of a conventional flow cytome-
ter, fluorescent labeling was used to improve FC detection of particles.
For fluorescent labeling of nonfluorescent bacteria Acridine Orange
(N,N,N′,N′-Tetramethylacridine-3,6-diamine)was used in 5𝜇g/mL final
concentration for 5 min at room temperature at pH = 3. Samples were
very gently sonicated (Bandelin Sonopuls HD 2070, 10% power) for
5 s to disrupt bacterial clumps and doublets. Our control measure-
ments agreed with previous findings37 and indicated that weak son-
ication did not interfere with bacterial viability and acridine orange
(AO) staining (data not shown). The fluorescence gate was set above
the endogenous fluorescence of nonlabeled bacteria detected by the
“green” fluorescence detector (530/30 nm). Bacteria were enumer-
ated in the R1 gate (Fig. 2C). To stay in the reliable detection range
of the cytometer and to avoid swarm detection an optimal flow range
was defined with a 10-fold dilution scale of fluorescent bacteria. The
flow rate was held during measurements under 1000 events/s (3750
events/𝜇L, dashed line in Fig. 2D). Furthermore, all samples were mea-
sured again after a 2-fold dilution to control linearity ofmeasurements.
FC data were analyzed with Flowing 2.5 Software (Turku Centre for
Biotechnology, Finland).
2.10 Statistics
Statistical analysis was performed using GraphPad Prism 6 for Win-
dows (La Jolla, California, USA) and P-values < 0.05 were considered
as significant.
3 RESULTS AND DISCUSSION
3.1 Bacterial survival in different solutions with or
without neutrophils
Antibacterial assays are usually carried out in media not supporting
bacterial growth such as PBS or HBSS. Incubation in such media pro-
vides the initial bacterial count, but these tests only allow detection
of bactericidal but not bacteriostatic effects. In our antibacterial assay
initial bacterial count was defined by the “no growth” sample (marked
as 100% bacterial survival) and HBSS + 4% LB was used as general
assay solution. The diluted broth ensuresmoderate growth that can be
inhibited by bacteriostatic effects. Samples containing bacteria under
different conditions were divided and bacterial count was determined
in parallel by two or three independent methods.
As shown in Fig. 3A, incubation of bacteria for 40 min in pure HBSS
had no effect, whereas incubation in HBSS + 4% LB resulted in almost
doubling of the bacterial count. Next neutrophilic granulocytes (PMN)
were coincubated so that the cell to bacteria ratio was altered hun-
dredfold. Under all conditions bacterial count was significantly dimin-
ished by the end of 20 or 40 min. Analysis of the results obtained by
CFU counting compared to the OD and the FC-based methods is pre-
sented in Fig. 3B. Very strong correlation was obtained between CFU
counting and both other testedmethods.
In the following experiments, results of the new FC-based method
were only compared to the OD-based method that offers higher
throughput and requires less manual labor. First, we tested our assay
with different bacterial strains. In case of the GFP-expressing S. aureus
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F IGURE 3 Comparison of the FC-based method with previously applied techniques for measuring bacterial survival in different circum-
stances. (A) Survival of GFP expressing S. aureus (USA300) at different PMN to bacteria ratio and killing time. (B) Correlations of OD and FC-based
methods to CFU counting. (C–E) Survival in different media with or without PMN present of USA300 (C), AO stained S. aureus strain (D), and AO
stained E. coli strain (E). Black, gray, and white bars represent results obtained by the CFU counting, OD-based and FC-basedmethod, resp.; (n= 6;
mean+ SEM; Significancewas calculated in relation to the assay solutionHBSS+ 4% LB, †, *, and # represent P< 0.05; two sample Student’s t-test)
strain,USA300moderate but clear growth was detected in HBSS+ 4%
LB with both techniques (Fig. 3C). The weak detergent saponin, used
in our assay to release viable bacteria from PMN, did not signif-
icantly interfere with the growth of the GFP-expressing S. aureus
strain (Fig. 3C). The significant antibacterial effect of neutrophils
(PMN/bacteria = 1:10) was evident in both assays. As methodological
referencepoints, bacterial survivalwasalso tested inHBSS (nogrowth)
and in LB (maximal growth). In HBSS the expected 100% survival rate
was detected and the calculated SD of measurements was very low in
both assays. In contrast, significant difference was observed between
the compared two techniques when bacteria were grown in LB
(Fig. 3C; see later in details).
We carried out the same experiments with two other bacterial
strains that did not express endogenous fluorescent protein. These
bacteria were stained with AO for the FC measurement. Wild type
S. aureus showed the same survival pattern as the GFP-expressing
strain (Fig. 3D). The gram-negative E. coli was moderately affected by
the detergent saponin and more effectively eliminated by PMN than
S. aureus strains (Fig. 3E). These differences between S. aureus and E.
coli fit to previous findings on different sensitivity of the two strains
to PMN.8 Taken together we show that the test works equally well for
gramnegative and gram-positive bacteria andwith bacteria expressing
fluorescent protein or stained with a simple fluorescent dye.
3.2 Antibacterial effect of different blood cells
To test the wider applicability of the new FC-based method, the
antibacterial effect of other blood cells was also investigated. Com-
pared to the control, both PMN andmonocytes decreased the survival
of S. aureus in contrast to erythrocytes that had no antibacterial effect,
demonstrating that inert cellular material itself does not modify or fal-
sify themeasured result (Fig. 4A).
In order to test a clinically relevant alteration of killing ability, we
investigated neutrophils from wild type and NADPH oxidase (NOX2)
knockout mice deficient in the membrane-localized subunit of the
enzyme.35 Both methods showed significant difference in bacterial
killing between wild type and NOX2 knock-out murine PMN after a
40 min test (Fig. 4B). Specificity and sensitivity of the two methods
were calculated from the data presented in Fig. 4B and proved to be
very similar. Killing was regarded effective when bacterial survival
was smaller than the lower 95% confidence limit of bacterial survival
in HBSS (90.31%). Specificity was 81% for the OD-based technique
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F IGURE 4 Testing of the antibacterial effect of different blood cells and subcellular particles. Gray and white bars represent results obtained
by the OD-based and FC-based method. (A) Effect of human blood cells on AO stained S. aureus. (n = 7 or 6 (in case of erythrocyte), mean + SEM, *
and # represent P < 0.05 in relation to HBSS + 4%, two sample Student’s t-test). (B) Antibacterial effect of 11–14-week-old male murine wild type
(C57Bl/6J) and NOX2KO (NOX2−/0) PMN onGFP expressing S. aureus (USA300). (n= 11 (WT), and 9 (KO)mean+ SEM, * represents P< 0.05, two
sample Student’s t-test). The dotted line represents the lower 95% confidence limit of bacterial survival in HBSS (90.31%). (C–E) Dose-dependent
antibacterial effect of PMN-derived EV: (C) Survival ofUSA300 (n= 8) (D) AO stained S. aureus strain (n= 6), and (E) AO stained E. coli strain (n= 6);
mean+ SEM, * and # represent P< 0.05 in relation to heat inactivated EV (H.I. EV)
and 91% for the FC-based technique. Sensitivity was identical for both
techniques (89%). The present findings are in agreementwith previous
observations on superoxide-dependent elimination of S. aureus by
Rada et al.8] and lack of superoxide production in NOX2-deficient
neutrophils.35
3.3 Dose-dependent effect of PMN-derived
extracellular vesicle (EV) on bacteria
Next, we asked the question whether our new FC-based method was
suitable for detection of the antibacterial effect of subcellular parti-
cles. As we and others showed before, activated PMNproduce EV that
impair the growth of both gram positive and negative bacteria.14,38,39
However, dose dependency of EV-mediated antibacterial effect
was not showed before. In our previous experiments, we tested
the antibacterial effect of EV produced by 1 × 107 activated PMN
(referred to as “1 EV”). In the current experiments, we tested a broader
range from tenfold diluted to fivefold concentrated EV preparations
on all three bacterial strains (Fig. 4C–E). The antibacterial effect was
evident with all three tested bacteria, but their sensitivity proved to
be different. When testing the USA300 strain statistically significant
effect was attained at “1 EV” concentration. In case of the two other
bacterial strains, statistically significant antibacterial action was only
brought about by fivefold concentrated EV preparation.
3.4 Reproducibility of the results
To examine the reproducibility of our new FC-based assay we com-
pared survival of S. aureus inHBSS+4%LB in thepresenceandabsence
of PMN as determined in five separate experimental series (in each
series 6 or 8 identical experiments were carried out within onemonth)
(Fig. 5A). PMN effectively reduced bacterial survival in all five exper-
imental series detected by either technique, although the FC-based
method seemed to produce more homogenous results. In the absence
of PMNvery similar bacterial growthwasdetectedbyboth techniques,
although the deviation was smaller in case of the FC-based method
(Fig. 5A).
In Fig. 5B the result of every single experiment of the five series is
presented by one dot. The mean of the total of 32 experiments carried
out with the two different methods fits very well but the deviation of
individual data is significantly lower in case of the FC-basedmethod.
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F IGURE 5 Comparison of the reproducibility of the FC-based andOD-basedmethods. (A) Bacterial survival of S. aureus in five separate exper-
imental series with or without PMN present (test medium was HBSS + 4% LB in all cases). In each series 6–8 experiments were carried out
(mean + SEM). (B) Scattering of every single measurement of S. aureus survival in the presence of PMN (n = 32, mean ± SD). F-test showed signifi-
cant difference in variances of the two methods (signed as *); however, t-test with Welch’s correction showed nonsignificant difference in means.
(C) Summarized linear regression of bacterial survival measured byOD- and FC-basedmethods (n= 37,±SEM)
Figure 5C summarizes all the data of S. aureus survival presented in
Figs. 3–5. The high value of the linear regression coefficient indicates
good comparability of the two methods up to approx. 300% growth
rate. At very high growth rate, incubation of bacteria for 40 min in
nutrient rich medium resulted in an active reproductive state com-
pared to the quiescent “no growth” reference sample. This difference
significantly influenced the growing up time in the OD-based method
and led to overestimation of the initial bacterial count.
4 CONCLUSION
In our opinion, our new method offers advantages over all techniques
summarized in Table 1. However, the most important advantage is in
the time factor. Applying the new FC-based method, bacterial count
of the sample can be determined in 3 hours as compared to 16 hours
with the OD-based test and 48 hours of CFU counting. In cases of
symptomatic immunodeficiencies of unknown origin (congenital or
acquired), investigation of phagocytic functions, including bacterial
killing is recommended.40 In these cases, the time difference in obtain-
ing diagnostic results is critical. The proposed assay determines the
number of bacteria, thus no conversion or further processing of the
measured data is required. Depending on the property of the used
medium, i.e. whether it allows bacterial growth or not, both bacterio-
static and bactericidal effects can bemeasured.
Taken together, we propose a new, fast, easy, reliable, and repro-
ducible FC-based test that is suitable for high throughput quantitation
of bacteriostatic or bactericidal effect of any immune cell or noncel-
lular material and provides large potential both for research and for
clinical purposes.
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